Related Experiment Videos
Gene therapy with Adv-IL-2 in unresectable digestive cancer: phase I-II study, intermediate report
F N Gilly1, A Beaujard, J Bienvenu
1Surgical Department, Centre Hospitalo-Universitaire Lyon Sud, France.
Hepato-Gastroenterology
|August 3, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[New targets for new anti-herpes drugs].
Virologie (Montrouge, France)·2022
Adipocyte-conditioned medium induces resistance of breast cancer cells to lapatinib.
BMC pharmacology & toxicology·2020
Clinical Heterogeneity of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome: A French Multicenter Retrospective Study.
Clinical and translational gastroenterology·2018
TTC7A mutation must be considered in patients with repeated intestinal atresia associated with early inflammatory bowel disease: Two new case reports and a literature review.
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2018
Palliative Surgery for Gastric Cancer with Gastric Outlet Obstruction or Anemia due to Tumor Bleeding.
Hepato-gastroenterology·2016
Which Factors are Predictive for Mortality among Hospitalized Patients with Cirrhosis?
Hepato-gastroenterology·2016
Hydrodynamics Analysis and CFD Simulation of Portal Venous System by TIPS and LS.
Hepato-gastroenterology·2016
Silencing GJB2 attenuates IL-1β-induced chondrocyte injury by activating Nrf2/HO-1 signaling and preserving mitochondrial function.
Folia histochemica et cytobiologica·2026
DPM2 promotes melanoma progression and serves as a prognostic factor.
Melanoma research·2026
Efficacy of combined atorvastatin and paromomycin in treating experimental cryptosporidiosis in immunosuppressed mice.
QJM : monthly journal of the Association of Physicians·2026
Pan-RAS Inhibitor Shows Activity in Advanced Lung Cancer.
Cancer discovery·2026